MY165024A - PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT - Google Patents

PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT

Info

Publication number
MY165024A
MY165024A MYPI2013700437A MYPI2013700437A MY165024A MY 165024 A MY165024 A MY 165024A MY PI2013700437 A MYPI2013700437 A MY PI2013700437A MY PI2013700437 A MYPI2013700437 A MY PI2013700437A MY 165024 A MY165024 A MY 165024A
Authority
MY
Malaysia
Prior art keywords
igg
obtaining
heat treatment
igg composition
polymers
Prior art date
Application number
MYPI2013700437A
Other languages
English (en)
Inventor
Debart Pere Ristol
Gamon Salvador Grancha
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46053016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY165024(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of MY165024A publication Critical patent/MY165024A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A61K39/39525—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2013700437A 2012-03-20 2013-03-18 PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT MY165024A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230413A ES2381828B1 (es) 2012-03-20 2012-03-20 PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO

Publications (1)

Publication Number Publication Date
MY165024A true MY165024A (en) 2018-02-28

Family

ID=46053016

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013700437A MY165024A (en) 2012-03-20 2013-03-18 PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT

Country Status (21)

Country Link
US (1) US9200032B2 (https=)
EP (1) EP2641912B1 (https=)
JP (2) JP6048936B2 (https=)
KR (1) KR101840064B1 (https=)
CN (1) CN103319592B (https=)
AR (1) AR090337A1 (https=)
AU (1) AU2013201853B2 (https=)
BR (1) BR102013006411A2 (https=)
CA (1) CA2809513C (https=)
CL (1) CL2013000688A1 (https=)
ES (2) ES2381828B1 (https=)
HU (1) HUE027915T2 (https=)
IL (1) IL225197A (https=)
MX (1) MX339268B (https=)
MY (1) MY165024A (https=)
PL (1) PL2641912T3 (https=)
PT (1) PT2641912T (https=)
RU (1) RU2636049C2 (https=)
SG (1) SG193738A1 (https=)
TW (1) TWI554283B (https=)
UY (1) UY34679A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2990033A1 (fr) * 2014-08-26 2016-03-02 Carlina Technologies Procédé de préparation de nanoprécipites de peptide ou protéine de faible poids moléculaire
PT3135687T (pt) * 2015-08-31 2019-05-21 Inst Grifols S A Método para preparação de imunoglobulinas
RU2708394C2 (ru) * 2016-09-26 2019-12-06 Институто Грифольс,С.А. Способ получения иммуноглобулинов
MX2020010724A (es) * 2018-04-12 2020-11-06 Amgen Inc Metodos para preparar composiciones proteicas estables.
CN112557643B (zh) * 2019-09-26 2023-04-14 菲鹏生物股份有限公司 变性IgG和类风湿因子免疫抗原及制备方法
CN112858671B (zh) * 2019-11-27 2022-12-27 菲鹏生物股份有限公司 制备类风湿因子检测试剂的方法、类风湿因子检测试剂、试剂盒和检测方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US514375A (en) 1894-02-06 miller
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4165370A (en) 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4396608A (en) 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
ES8206184A1 (es) 1981-10-29 1982-08-16 Green Cross Corp Un procedimiento para preparar una immunoglobulina adecuada para inyeccion intravenosa
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0825902B2 (ja) 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US7378123B2 (en) * 2004-05-07 2008-05-27 Wisconsin Alumni Research Methods involving whey protein isolates
CN101679509A (zh) * 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
US8796430B2 (en) * 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
CA2809513C (en) 2016-09-27
IL225197A (en) 2017-06-29
AR090337A1 (es) 2014-11-05
MX2013002910A (es) 2013-09-19
KR101840064B1 (ko) 2018-03-19
ES2381828B1 (es) 2012-11-16
CL2013000688A1 (es) 2014-02-28
ES2590045T3 (es) 2016-11-17
CN103319592B (zh) 2020-03-03
PL2641912T3 (pl) 2016-11-30
MX339268B (es) 2016-05-18
CA2809513A1 (en) 2013-09-20
JP6048936B2 (ja) 2016-12-21
UY34679A (es) 2013-10-31
AU2013201853A1 (en) 2013-10-10
US9200032B2 (en) 2015-12-01
JP2016199586A (ja) 2016-12-01
BR102013006411A2 (pt) 2015-06-09
HUE027915T2 (en) 2016-11-28
EP2641912A1 (en) 2013-09-25
RU2013112276A (ru) 2014-09-27
HK1185625A1 (en) 2014-02-21
US20140113355A1 (en) 2014-04-24
PT2641912T (pt) 2016-08-12
EP2641912B1 (en) 2016-06-15
ES2381828A1 (es) 2012-06-01
RU2636049C2 (ru) 2017-11-17
TWI554283B (zh) 2016-10-21
AU2013201853B2 (en) 2014-07-03
SG193738A1 (en) 2013-10-30
KR20130106792A (ko) 2013-09-30
IL225197A0 (en) 2013-06-27
TW201343179A (zh) 2013-11-01
CN103319592A (zh) 2013-09-25
JP2013194054A (ja) 2013-09-30

Similar Documents

Publication Publication Date Title
JOP20210064B1 (ar) طريقة لانتاج ( z)-ألفا-فلورو-بيتا-أمينو-أكريل الدهيدات مستبدلة
MY165024A (en) PROCESS FOR OBTAINING AN IgG COMPOSITION THROUGH HEAT TREATMENT
EP3216867A4 (en) Method for modifying genome sequence to introduce specific mutation to targeted dna sequence by base-removal reaction, and molecular complex used therein
MX2019001056A (es) Purificacion de materia prima mediante tratamiento termico.
PH12014500557A1 (en) Methods for treating hcv
HK1206635A1 (en) Modified polynucleotides for the production of proteins
NZ758528A (en) Bicyclic heterocycle compounds and their uses in therapy
EA201491539A1 (ru) Улучшение засухоустойчивости у растений: пектинэстераза
EP2902106A4 (en) OXID CATALYST, PRODUCTION METHOD AND METHOD FOR PRODUCTION OF UNSATURATED ALDEHYDE, DIOLEFINE OR UNSATURATED NITRILE
MX366422B (es) Proceso para preparar un producto lacteo fermentado colado.
EP2837613A4 (en) AZEOTROPE OR AZEOPEOTROPIC COMPOSITION AND PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUORPROPEN OR CHLOROMETHANE
EP2826765A4 (en) PREPARATION FOR 2,3,3,3-TETRA-FLUORO-PROPOSES AND 1,1-DIFLUORETHYLENE
PH12016502220A1 (en) Means and methods for treating cmv
EA033335B1 (ru) Антитело к интерлейкину-21 и его применение для лечения аутоиммунного состояния
FR2978152B1 (fr) Nouveau procede de preparation de dialkylmagnesiens par polymerisation de l&#39;ethylene et leurs applications
TN2014000112A1 (en) Ep1 receptor ligands
IN2015KN00323A (https=)
MX343612B (es) Proceso para la preparacion de metoximelonal.
MX2015008944A (es) Proceso de liofilizacion.
MX2014006433A (es) Nuevos 2h-indazoles como antagonistas del receptor ep2.
EP2937326A4 (en) PREPARATION PROCESS FOR 1,3, 3,3-TETRAFLUORPROPEN
GB201100531D0 (en) Functionalised materials, processes for the production and uses thereof
EP3535302A4 (en) METHOD FOR PRODUCING A MODIFIED SERVED RUBBER, RUBBER AND COMPOSITION BASED ON IT
EP2930166A4 (en) PROCESS FOR THE PREPARATION OF 3-AMINOMETHYL-3,5,5-TRIMETHYLCYCLOHEXYLAMINE
EP2905315A4 (en) METHOD FOR PRODUCING A RUBBER COMPOSITION